维普中文期刊产品整合服务
14篇 您的检索式:作者名="Decosterd LA"
    题名 作者 年代 出处 被引量
1Midazolam premedication reduces propofol dose requirements for multiple anesthetic endpoints 显示文摘 Ravussin PA Decosterd LA 2001Can J Anaesth2001,48,:1
2Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV- l-infected patients 显示文摘Marzolini C Telenti A Decosterd LA 2001AIDS2001,15,1:1
3Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients 显示文摘Robatel C Decosterd LA Biollaz J 2003J Clin Pharmacol2003,43,:1
4Midazolam premedication reduces propofol dose requirements for multiple anesthetic endpoints显示文摘Wilder-Smith OH Ravussin PA Decosterd LA 2001Can J Anaesth2001,48,5:1
5A phase I pharmacokinetic study of hypoxic abdominal stop-flow perfusion with gemcitabine in patients with advanced pancreatic cancer and refraetorymalignant aseites显示文摘Kuemmerle A Decosterd LA Buelin T 2009Cancer Chemother Pharmaeol2009,63,2:1
6Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV infected patients显示文摘Marzolini C Telenti A Decosterd LA 2001AIDS2001,13,:1
7Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV- 1-infectedpatients显示文摘Marzolini C Telenti A Decosterd LA 2001AIDS2001,15,:1
8Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein 显示文摘Widmer N Decosterd LA Csajka C 2006Br J Clin Pharmacol2006,62,:1
9Phannacokinet- ics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial ad- ministration显示文摘Marzolini C Decosterd LA Shen F 1998Cancer Chemother Pharmacol1998,42,6:1
10Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients显示文摘MARZOLINI C TELENTI A DECOSTERD LA 2001AIDS2001,15,1:1
11Relationship of imatinib-free plasma levels and target genotype with ef- ficacy and tolerability显示文摘Widmer N Decosterd LA Leyvraz S 2008Br J Cancer2008,98,10:1
12Population pharmacokinetics of imatinib and the role of α-acid glycoprotein显示文摘Widmer N Decosterd LA Csajka C 2006Br J Clin Pharmacol2006,62,:1
13Relationship of imatinib-free plasma levels and target genotype with efficacy and tolerability显示文摘Widmer N Decosterd LA Leyvraz S 2008Br J Cancer2008,98,:1
14Midazolam premedi- cation reduces propofol dose requirements for multiple anesthetic endpoints 显示文摘Wilder OH Ravussin PA Decosterd LA 2001Can J Anaesth2001,48,5:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费